⌘K

Home/Filings/4/0001562180-19-000755

4//SEC Filing

Das Asha 4

Accession 0001562180-19-000755

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 11:10 AM ET

Size

5.4 KB

Accession

0001562180-19-000755

Insider Transaction Report

Form 4

Period: 2019-02-01

PROGENICS PHARMACEUTICALS INCPGNX

Chief Medical Officer

Transactions

Award
Non-Qualified Stock Option (Right to Buy)
2019-02-01+125,000→ 125,000 total
Exercise: $4.56Exp: 2029-02-01→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]5yr 20% On Vest beginning on 01-Feb-2019

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001701647

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 11:10 AM ET
Size: 5.4 KB

View on SEC.gov